REPORT HIGHLIGHT
The blood culture test market is estimated to represent a global market of USD 4.63 million by 2019 with growth rate of 8.1%.

Blood culture tests are widely used to detect the presence of foreign invaders, i.e. fungi or bacteria in blood samples. These cultures are collected for testing in order to check the cause of various infections inpatient. As per the article published in the Journal of Clinical Microbiology, every year, more than 20 million blood cultures are ordered in the U.S. alone.

Market Dynamics
Technological advancements are expected to be a major factor driving the market growth. Advancement in technologies has helped this field to provide better accuracy, reliability in disease diagnosis and to avoid unnecessary healthcare costs. For instance, an introduction of an automated microbial detection system, BacT ALERT 3D (bioMérieux) allows immediate bottle recognition with a low false positive rate and rapid response rate. This system is easy to use, save time, and prevent major test errors. Similarly, development of technologies targeted real-time PCR technique, and peptide nucleic acid fluorescent in situ hybridization (PNA-FISH) plays a strategic role in fostering the change of blood culture industry towards better health outcomes.

In addition, rising number of hospital admissions has led to rise in the incidence of hospital-acquired infections. For example, according to the World Health Organization (WHO), hospital-acquired infection is the most frequent adverse event in healthcare delivery across the globe. The organization stated that of the 100 hospitalized patients, 10 in developing and 7 in developed region acquire at least one healthcare-associated infection every year. Thus, the demand for effective and advanced blood testing techniques appear to be growing at strong growth rate for the treatment and diagnosis of various infectious diseases, augmenting the market growth. On contrary, the market has been stifled by some key barriers to growth. The foremost among these is the strict regulatory requirements and a high cost for some laboratory methods.

Product Takeaway

In terms of products, the market is categorized into instrument, consumables, and services. Consumables segment accounted for the largest share of the total market, captured more than 56% in 2019. This segment is further classified into Media, Assay kits and reagents, and Accessories. Whereas, instrument segment is divided into laboratory equipment and automated blood culture systems. Depending upon technique, the market is segmented as conventional and automated. With the convergence of various scientific and technological breakthroughs, the pace of automated blood culture test segment is accelerating.

COVID-19 Impact and Recovery Analysis
The novel COVID-19 has put the world on a standstill, affecting major operations, leading to an industrial catastrophe. However, the global blood culture test market is positively affected due to this outbreak. This report presented by AnalystView Market Insights contains a thorough analysis of the pre and post COVID-19 market scenarios. The report includes all the recent development and changes recorded during the COVID-19 outbreak and comprehends the analysis of top performer segments and marginal growth segment in blood culture test sector.

Regional Takeaway

Regionally, the global industry is dominated by the North America market. In 2019, this region is accounted for more than 42% share of the total industry. The growth of the regions is primarily attributed to the increasing incidence of infectious diseases coupled with the growing demand. On contrary, currently, this industry in developing regions such as the Asia Pacific and Latin America is small but rapidly expanding.

Key Vendor Takeaway

Companies such as Thermo Fisher Scientific, bioMérieux, Abbott, Alere, and Bruker are profiled in the study. Majority of these companies were witnessed to have an extensive product offering coupled with strong regional presence. The key player is profiled based on attributes such as company overview, financial performance, SWOT analysis, and key developments.

The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.

The years considered for the study are:

Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027

The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL BLOOD CULTURE TEST MARKET, BY PRODUCT
Instrument
Laboratory Equipment
Automated Blood Culture
Consumables
Media
Assay kits and Reagents
Accessories
Services

GLOBAL BLOOD CULTURE TEST MARKET, BY TECHNIQUE
Conventional
Automated

GLOBAL BLOOD CULTURE TEST MARKET, BY TECHNOLOGY
Molecular
Culture-based
Proteomic

GLOBAL BLOOD CULTURE TEST MARKET, BY APPLICATION
Fungal Infections
Bacterial Infections
Others

GLOBAL BLOOD CULTURE TEST MARKET, BY END USE
Reference Laboratories
Hospitals
Others

GLOBAL BLOOD CULTURE TEST MARKET, BY REGION
North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America